Inositol polyphosphate 4-phosphatase (4-phosphatase) is an enzyme that catalyses the hydrolysis of the 4-position phosphate from phosphatidylinositol 3,4-bisphosphate [PtdIns(3,4)P 2 ]. In human platelets the formation of this phosphatidylinositol, by the actions of phosphatidylinositol 3-kinase (PI 3-kinase), correlates with irreversible platelet aggregation. We have shown previously that a phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase forms a complex with the p85 subunit of PI 3-kinase. In this study we investigated whether PI 3-kinase also forms a complex with the 4-phosphatase in human platelets. Immunoprecipitates of the p85 subunit of PI 3-kinase from human platelet cytosol contained 4-phosphatase enzyme activity and a 104-kDa polypeptide recognized by specific 4-phosphatase antibodies. Similarly, immunoprecipitates made using 4-phosphatase-specific antibodies contained PI 3-kinase enzyme activity and an 85-kDa polypeptide recognized by antibodies to the p85 adapter subunit of PI 3-kinase. After thrombin activation, the 4-phosphatase translocated to the actin cytoskeleton along with PI 3-kinase in an integrin-and aggregation-dependent manner. The majority of the PI 3-kinase͞ 4-phosphatase complex (75%) remained in the cytosolic fraction. We propose that the complex formed between the two enzymes serves to localize the 4-phosphatase to sites of PtdIns(3,4)P 2 production.
Following agonist-induced cellular activation, two distinct pathways of phosphatidylinositol (PtdIns) metabolism have been well characterized. Phosphatidylinositol 4,5-bisphosphate [PtdIns(4,5)P 2 ] hydrolysis by phospholipase C produces soluble inositol phosphates and diacylglycerol (1, 2) . Phosphatidylinositol 3-kinase (PI 3-kinase) phosphorylates phosphatidylinositol in the D3 position of the inositol ring, forming phosphatidylinositol 3-phosphate (PtdIns3-P), phosphatidylinositol 3,4-bisphosphate [PtdIns(3,4)P 2 ], and phosphatidylinositol 3,4,5-trisphosphate [PtdIns(3,4,5)P 3 ], respectively (reviewed in refs. 3 and 4) . Downstream targets of PtdIns(3,4,5)P 3 and PtdIns(3,4)P 2 include various isoforms of protein kinase C and the serine͞threonine kinase Akt (5, 6) . The activation of Akt via these 3-position polyphosphatidylinositols serves to regulate apoptosis and, thereby, cell survival (7, 8) .
Thrombin stimulation of platelets results in a rapid transient formation of PtdIns(3,4,5)P 3 and PtdIns(3,4)P 2 (9) (10) (11) (12) . After platelet aggregation a sustained, delayed accumulation of PtdIns(3,4)P 2 occurs, which is mediated by wortmannininhibitable generation of PtdIns3-P, followed by phosphorylation by a specific PtdIns3-P 4-kinase (13) (14) (15) . This pathway requires activation of the calcium-dependent protease calpain. The production of PtdIns(3,4,5)P 3 and PtdIns(3,4)P 2 correlates with the translocation of PI 3-kinase to the platelet actin cytoskeleton and an increase in PI 3-kinase enzyme activity (12, 16) .
Inositol polyphosphate 4-phosphatase (4-phosphatase) is a 105-kDa Mg 2ϩ -independent enzyme that hydrolyzes the 4-position phosphate from the inositol ring of inositol 1,3,4-trisphosphate [Ins(1,3,4)P 3 ], inositol 3,4-bisphosphate [Ins(3,4)P 2 ], and PtdIns(3,4)P 2 (17, 18) . Kinetic analysis suggests that the phospholipid is the preferred substrate. Two cDNAs encoding 4-phosphatases types I and II have been cloned that predict proteins with 37% amino acid identity (19, 20) . The enzymatic properties of the isoforms are similar, and both 4-phosphatases are widely expressed. A role for calpainmediated inactivation of the 4-phosphatase in the calcium-and aggregation-dependent accumulation of PtdIns(3,4)P 2 in thrombin-activated platelets has been demonstrated recently (21) .
It was shown previously that an inositol polyphosphate 5-phosphatase forms a complex with the p85 subunit of PI 3-kinase (22) . The p85-associated 5-phosphatase has a unique substrate specificity, in that the enzyme only hydrolyses PtdIns(3,4,5)P 3 to form PtdIns(3,4)P 2 . Liu et al. (23) have also demonstrated a similar 5-phosphatase, constitutively associated with the p85 subunit of PI 3-kinase, which forms a complex with the IL-3 receptor (23) . In this report, we show that analogous to the p85-associated 5-phosphatase, the 4-phosphatase I also associates with the p85 subunit of the PI 3-kinase in vivo in human platelet cytosol and, thereby, may enable localization of the 4-phosphatase to sites of PtdIns(3,4)P 2 production.
EXPERIMENTAL PROCEDURES
Platelet Subcellular Fractionation. Human platelets were obtained and washed, and subcellular fractions were isolated as described (24) . In experiments determining Ins(1,3,4)P 3 4-phosphatase activity in the cytoplasmic actin cytoskeleton, the washed cytoskeletal pellet was resuspended in 20 mM Tris, pH 7.2͞150 mM NaCl.
Affinity Capture of PI 3-Kinase. The peptide (Y751) CDES-VDY P VPML (where Y p represents phosphotyrosine), which corresponds to the binding site on the platelet-derived growth factor ␤ receptor for the p85 subunit of PI 3-kinase, was coupled to Actigel Superflow resin (Sterogen, Arcadia, CA), as described (25) . Sixty microliters of the Y751 peptidecoupled resin was mixed with 600 l of platelet cytosol overnight at 4°C. The resin was pelleted and washed either three times with 1 ml of low-stringency buffer (20 mM Tris, pH 7.2͞5 mM MgCl 2 ͞1 mM EDTA) followed by 1 ml ϫ three
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Abbreviations: 4-phosphatase, inositol polyphosphate 4-phosphatase; PtdIns(3,4)P2, phosphatidylinositol 3,4-bisphosphate; PtdIns3-P, phosphatidylinositol 3-phosphate; PI 3-kinase, phosphatidylinositol 3-kinase; Ins (1, 3, 4) times with kinase assay buffer (20 mM Hepes, pH 7.4͞1 mM EGTA͞5 mM MgCl 2 ) or three times with 1 ml of highstringency buffer (10 mM Tris, pH 7.2͞0.5 M NaCl͞1 mM EDTA͞1% NP-40͞0.1% SDS), followed by three times with 1 ml of kinase assay buffer.
Antibodies. The C-terminal 4-phosphatase antipeptide antibody was developed as described (19) . The N-terminal 4-phosphatase antipeptide antibody was raised against amino acids 1-16 MTAREHSPRHGARAR in the type I 4-phosphatase. The peptide was coupled to keyhole limpet hemocyanin with N-hydroxysuccinimide ester, and antigen was injected into rabbits by Pocono Rabbit Farm (Canadensis, PA).
Immunoprecipitation of Inositol Polyphosphate 4-Phosphatase. Five microliters of polyclonal antisera directed to either an N-terminal or C-terminal type I 4-phosphatase peptide was incubated overnight at 4°C with 600 l of human platelet cytosol (5 mg͞ml) and 60 l of a 50% slurry of protein A-Sepharose. Pelleted immunoprecipitates were washed with 1 ml ϫ 6 of 20 mM Tris, pH 7.4͞150 mM NaCl.
Immunoprecipitation of the p85 Subunit of the PI 3-Kinase. The p85 subunit of PI 3-kinase was immunoprecipitated from human platelet cytosol by using 5 l of polyclonal antibody to the p85 subunit (Upstate Biotechnology, Lake Placid, NY). The conditions for immunoprecipitation were as those for the 4-phosphatase.
Inositol Polyphosphate 4-Phosphatase Assay. The immunoprecipitates or immunodepleted samples (2, 3, 5, or 10 l) were incubated with [ 3 H]Ins(1,3,4)P 3 (16 M, 16,680 cpm͞ nmol) in 100 l 50 mM Mes, pH 6.5͞5 mM EDTA at 37°C for 15 min, and products of the reaction were analyzed as described (18) . PI 3-Kinase Assay. Platelet PI 3-kinase captured on Actigel Superflow resin or protein A-Sepharose pellets with associated anti-p85 or anti-4-phosphatase immune complexes were washed three times with ice-cold 20 mM Tris, pH 7.4͞150 mM NaCl͞1 mM sodium orthovanadate͞250 g/ml phenylmethylsulfonyl fluoride, followed by three washes with ice-cold kinase assay buffer (20 mM Hepes, pH 7.4͞1 mM EGTA͞5 mM MgCl 2 ). Immunoprecipitates were resuspended in kinase assay buffer and mixed with either sonicated PtdIns (200 M) and PtdSer (300 M), or PtdIns 4-P (200 M) and PtdSer (300 M), and [␥-32 P]ATP (50 M, 1 Ci͞nmol) to a final reaction volume of 100 l. The reactions were stopped after 20 min at room temperature, lipid products were analyzed by TLC (22) , and the identity of deacylated lipid products was confirmed as described (26) .
RESULTS AND DISCUSSION
PtdIns(3,4)P 2 4-Phosphatase Associates with PI 3-Kinase in Human Platelet Cytosol. We have shown previously that a PtdIns(3,4,5)P 3 5-phosphatase forms a stable complex with the p85 subunit of PI 3-kinase (22) . We investigated whether the 4-phosphatase, which dephosphorylates the 4-position phosphate from PtdIns (3,4)P 2 , forming PtdIns3-P, also associates with the p85 subunit of PI-3-kinase. The phosphorylated peptide (CDESVDY P VPML), which represents the p85-binding domain of the platelet-derived growth factor ␤ receptor, was coupled to Actagel Superflow resin, and PI 3-kinase was affinity-captured from platelet cytosol. PI 3-kinase assays were performed with affinity-captured enzyme, using PtdIns 4-P as substrate (Fig. 1) . After washing of the resin with low-stringency buffer (20 mM Tris, pH 7.4͞150 mM NaCl), two lipid reaction products, PtdIns (3,4)P 2 and PtdIns3-P, were observed. In this assay, PtdIns(3,4)P 2 is synthesized by the affinity-captured PI 3-kinase and subsequently is hydrolyzed to PtdIns3-P by a PtdIns(3,4)P 2 4-phosphatase, which complexes with the kinase. Disassociation of the PtdIns(3,4)P 2 4-phosphatase͞PI 3-kinase complex was achieved after washing the peptide affinity resin with 10 mM Tris, pH 7.2͞0.5 M NaCl͞1 mM EDTA͞1% NP-40͞0.1% SDS. PI 3-kinase activity still was demonstrated by the observed production of PtdIns(3,4)P 2 , but no PtdIns(3,4)P 2 4-phosphatase activity was detected. These studies suggest PtdIns(3,4)P 2 4-phosphatase activity is not intrinsic to PI 3-kinase, but may complex with either the p85 adapter or p110 catalytic subunit of PI 3-kinase, or with another protein that, in turn, binds to p85 or p110.
Two isoforms of 4-phosphatases (types I and II) have been identified (19, 20) . Both isoforms hydrolyze Ins(1,3,4)P 3 , Ins(3, 4)P 2 , and PtdIns(3,4)P 2 , forming inositol 1,3-bisphosphate [Ins(1,3)P 2 ], inositol 3-phosphate, and PtdIns3-P, respectively. To further characterize the PtdIns(3,4)P 2 4-phosphatase that complexes with PI-3 kinase, increasing amounts of immune serum to the p85 subunit of the PI-3-kinase were incubated with platelet cytosol, and immune complexes were captured on protein A-Sepharose. Ins(1,3,4)P 3 4-phosphatase activity was determined in both the supernatant and pellet of the immunoprecipitations. A dose-dependent increase in Ins(1,3,4)P 3 4-phosphatase activity was observed in protein A-Sepharose pellets, with increasing amounts of antiserum to the p85 subunit of PI 3-kinase ( Fig. 2A) . Loss of Ins(1,3,4)P 3 4-phosphatase activity was observed in the supernatant of immunoprecipitation reactions (results not shown). These studies demonstrate that the PtdIns(3,4)P 2 4-phosphatase, which complexes with PI 3-kinase, also hydrolyses Ins(1,3,4)P 3 and, therefore, may represent a previously characterized 4-phosphatase.
To support this contention, PI 3-kinase enzyme activity was determined in 4-phosphatase immunoprecipitates. Antipeptide antibodies to the N-terminal region of the type I 4-phosphatase recognize only the type I 4-phosphatase, whereas antibodies to the C-terminal peptide of the type I 4-phosphatase recognize both the type I and II isoenzymes (19) . Similar PI 3-kinase enzyme activity was detected by using both N-and C-terminal 4-phosphatase antipeptide antibodies (Fig. 2B) . That the N-terminal antibody is specific for the type I 4-phosphatase implies it is the predominant 4-phosphatase isoform associating with the PI 3-kinase. Immunoprecipitation of PtdIns 3-kinase activity was much less (1.14%, SD Ϯ 0.12%, n ϭ 5) in 4-phosphatase compared with p85 immunoprecipi-FIG. 1. PI 3-kinase was affinity-purified from platelet cytosol. A peptide (Y751) corresponding to the p85-binding site on the plateletderived growth factor receptor was coupled to Actigel Superflow resin. Six hundred microliters of human platelet cytosol (12 mg͞ml) was incubated with 60 l of a 50% slurry of the peptide-coupled resin. The resin was pelleted and washed with either (1) low-stringency or (2) high-stringency buffer. PI 3-kinase assays were performed on washed pellets in duplicate by using PtdIns 4-P as substrate.
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Proc. Natl. Acad. Sci. USA 96 (1999) tations. However, we cannot exclude that the 4-phosphatase antibody sterically inhibits PI 3-kinase enzyme activity under the assay conditions used or that complexing with 4-phosphatase reduces its activity. Western blot analysis of p85 or 4-phosphatase immunoprecipitates was undertaken by using antibodies to either the phosphatase or kinase, respectively. Immunoblot analysis of p85 immunoprecipitates demonstrated a 104-kDa polypeptide detected by 4-phosphatase antibodies, consistent with the presence of the type I 4-phosphatase in a complex with the p85 subunit of the PI 3-kinase (Fig. 3A) . The 4-phosphatase immunoprecipitated by p85 antibodies represented approximately 10% of that observed in 4-phosphatase immunoprecipitates, as determined by densitometric analysis. Western blot analysis of 4-phosphatase immunoprecipitates using p85 antiserum demonstrated the presence of an 85-kDa polypeptide, which comigrated with immunoprecipitated PI 3-kinase (Fig. 3B) . Densitometric analysis of 4-phosphatase immunoprecipitates revealed that the p85 detected represented 13% of that observed in p85 immunoprecipitations.
Translocation of 4-Phosphatase to the Thrombin-Activated Cytoskeleton.
Thrombin stimulation of human platelets results in a relocation of the p85 subunit of PI 3-kinase to the cytoskeleton, which correlates with the formation of PtdIns(3,4)P 2 and irreversible platelet aggregation (9, 10, 12, 16). We investigated whether the 4-phosphatase translocated to the actin cytoskeleton of thrombin-activated platelets. No 4-phosphatase was present in the actin cytoskeleton of resting platelets. However, a time-dependent translocation of 4-phosphatase to the cytoskeleton of thrombin-stimulated platelets was observed, which temporally correlated with the translocation of the p85 subunit of PI 3-kinase (Fig. 4A) . Densitometric analysis of the intensity of the immunoreactive 104-kDa 4-phosphatase in the cytosol of nonstimulated platelets compared with the actin cytoskeleton after 5-min thrombin activation demonstrated that 15% (SD Ϯ 2.5%, n ϭ 5) of the total cytosolic 4-phosphatase translocated. Similar analysis of p85 translocation under the same conditions revealed that 36% (SD Ϯ 8.6%, n ϭ 8) of the enzyme accumulated in the thrombin-activated cytoskeleton, consistent with previous reports (12) . Cytoskeletal translocation of the 4-phosphatase also was shown by Ins(1,3,4)P 3 4-phosphatase activity in the cytoskeleton of thrombin-activated, but not resting, platelets (Fig. 4B) . The specific activity of cytoskeletal vs. cytosolic 4-phosphatase was determined by densitometric analysis of immunoreactive 4-phosphatase in subcellular fractions per unit of enzyme activity and showed the enzyme was activated 3-fold in the cytoskeletal fraction, as shown in Table 1 . Translocation of the 4-phosphatase to the actin cytoskeleton depended on both platelet aggregation and integrin engagement, because 4-phosphatase relocation was not observed when the platelets were not stirred or were preincubated with RGDS peptide (Fig. 4C) .
A 36% (SD Ϯ 6.8, n ϭ 5) decrease in cytosolic Ins(1,3,4)P 3 4-phosphatase activity was routinely observed after thrombin stimulation. However, this decrease in enzyme activity does not result only from 4-phosphatase translocation to the actin cytoskeleton. Rather, previous studies have shown platelet activation with calcium ionophore or thrombin results in calpain-mediated proteolysis of 4-phosphatase (21) .
We have observed previously that the PtdIns(3,4,5)P 3 5-phosphatase that forms a complex with the p85 subunit of PI 3-kinase remains in the cytosolic fraction after thrombin stimulation, whereas the p85 subunit translocates to the activated actin cytoskeleton (22) . Complex formation between the 4-phosphatase and PI 3-kinase was determined in the cytosol and actin cytoskeleton of resting and thrombin-stimulated platelets. Platelet subcellular fractions were immunoprecipitated by using antibodies to the 4-phosphatase, captured on protein A-Sepharose, and immunoblotted using PI 3-kinase antiserum. The PI 3-kinase͞4-phosphatase complex remained stable in the cytosolic fraction of thrombin-activated platelets (Fig. 5) . A small decrease (23%, n ϭ 4) in the amount of complex between the two enzymes was determined by densitometric analysis of p85 immunoblots of 4-phosphatase im- Proc. Natl. Acad. Sci. USA 96 (1999) munoprecipitates in the cytosol after thrombin stimulation, compared with resting cells. In the actin cytoskeleton of unstimulated platelets, no PI 3-kinase͞4-phosphatase complex was detected. However, after thrombin activation, the PI 3-kinase͞4-phosphatase complex was observed in the thrombin-activated actin cytoskeleton. In human platelets there is a rapid, early formation of PtdIns(3,4,5)P 3 and PtdIns(3,4)P 2 , but not PtdIns3-P, after thrombin stimulation, which probably is generated by PI 3-kinase phosphorylation of PtdIns(4,5)P 2 and PtdIns 4-P. Dephosphorylation of PtdIns(3,4,5)P 3 by inositol polyphosphate 5-phosphatases also can form PtdIns(3,4)P 2 (2, 9, 11, 12) . Aggregation-dependent formation of PtdIns(3,4)P 2 recently has been described that is generated by the action of PtdIns3-P-4-kinase (13) (14) (15) . Phosphatidylinositol phosphate 5-kinases (types I and II) phosphorylate PtdIns3-P in the 4-position, forming PtdIns(3,4)P 2 (27) . Calpain-mediated proteolysis of 4-phosphatase also is responsible for calcium-and aggregation-dependent accumulation of PtdIns(3,4)P 2 in thrombinstimulated platelets (21) .
In this study we have demonstrated that 4-phosphatase is associated with PI 3-kinase in the cytosolic fraction of nonstimulated platelets and in the thrombin-activated cytoskeleton. We propose that this association serves to localize the phosphatase to sites of PtdIns(3,4)P 2 production. The mechanism mediating association between the 4-phosphatase and PI 3-kinase has yet to be determined. A complex between the kinase and phosphatase may be mediated by the p85 SH3 domain associating with proline-rich motifs present in the 4-phosphatase and is the subject of current investigation in the laboratory.
Using densitometry of the amount of 4-phosphatase in p85 immunoprecipitates compared with 4-phosphatase immunoprecipitates, approximately 10% of the cytosolic 4-phosphatase is in complex with the p85 subunit of the PI 3-kinase. This association appears functionally significant, because we always demonstrate hydrolysis of the 4-position phosphate of PtdIns(3,4)P 2 in affinity-purified PI 3-kinase preparations or in PI 3-kinase derived from platelet-cytosolic p85 immunoprecipitations.
After thrombin-stimulated platelet activation, both the PI 3-kinase and the 4-phosphatase translocate to the actin cytoskeleton, which requires both integrin engagement and platelet aggregation. The accumulation of 4-phosphatase in the cytoskeleton is associated with enzyme activation. The 3-fold activation of the 4-phosphatase correlates with p85 enzyme activation in the thrombin-activated cytoskeleton. Previous studies have shown that 29% of the cytosolic p85 translocates to the activated cytoskeleton, accompanied by a significant increase in PI 3-kinase activity, PtdIns(3,4)P 2 production, cytoskeletal accumulation of pp60 c-src , p125 FAK , and platelet aggregation (12) . The concomitant translocation and activation of 4-phosphatase to the thrombin-activated actin cytoskeleton provides a mechanism for increased hydrolysis of PtdIns(3,4)P 2 after its synthesis by the activated PI 3-kinase.
Recent studies have shown that the inositol polyphosphate 4-phosphatases and 5-phosphatases function to negatively regulate signals transmitted by phosphatidylinositols. We have shown that both 4-phosphatase and 5-phosphatase can form a complex with PI 3-kinase. The recruitment of the kinase and phosphatase into a signaling network provides a means for the localized amplification and degradation of phosphatidylinositol signals at critical sites after cellular activation.
